SALT LAKE CITY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced its support for a recent guideline update ...
A research team led by Zhen-Xing Endowed Professor Jian Yang at the School of Life Sciences, Westlake University, has ...
What if you could take a test to help you catch, or even prevent, cancer? A free genetic screening study through Sanford ...
Expansion of genetic testing to the general population is one of the ambitions of the UK Government's 2025 10-year Health Plan for England, as part of a strategy for transition from “sickness to ...
The NCCN's new resource educates patients on genetic testing for hereditary cancer risk, focusing on breast, ovarian, pancreatic, and prostate cancers. Advances in genetic technology, spurred by the ...
A multi-institution research team led by the University of Illinois — with sustained funding from the North Central Soybean ...